Piribo: New publication announcement, Competitive Outlook on Non-Antibody Based Cancer Vaccines

Introduction
New approaches in vaccines, such as DNA vaccines, new combination vaccines, new formulations, novel delivery routes, new adjuvants are being explored. In the last three years the cancer vaccine industry has reshaped itself quite considerably. The number of cancer vaccine players has rather decreased than increased, through operational re-prioritizations, M&As and fall outs.

Scope of this report
In-depth competitive landscape assessment of the cancer vaccine market Tumor antigen discovery and technologies surrounding it Thorough review of immunomodulating strategies and adjuvants Thorough review of cancer vaccine delivery and technologies surrounding it Progress analysis of six major cancer vaccine indications, including players, drugs, clinical progress and pitfalls

Research and analysis highlights
Research and development in the cancer vaccine field is dominated by its top 10 players, interestingly not including any of the big pharma companies per se. The recent Gardasil approval and GlaxoSmithKline’s acquisition of Corixa will certainly push the industry towards more acquisitions. With this in mind, this report makes an in-depth assessment of competitive landscape, tumor antigen technologies, immunostimulatory strategies, vaccine delivery technologies, and a progress analysis of six major cancer vaccine indications.

Key reasons to read this report
Understand the clinical and strategic challenges to the commercialization of cancer vaccines Assess opportunities and risks for the continued development of cancer vaccines in six major cancer indications. Adopt knowledge from this analysis to drive strategic planning decisions in oncology drug development

Contents
1 Executive Summary
2 Cancer Highlights
3 Methodology
4 Table of Contents
5 Vaccine Strategies: Challenges & Opportunities
6 Competitive Landscape in Cancer Vaccines
7 Tumor Antigens
8 Immunomodulators & Adjuvants in Cancer Vaccines
9 Cancer Vaccine Delivery
10 Non-Antibody Based Vaccines in Development: By Major Indications
11 Disclaimer
12 Drug Index
13 Company Index

“Competitive Outlook on Non-Antibody Based Cancer Vaccines” is available from Piribo. For more information go to: http://www.piribo.com/publications/diseases_conditions/cancer/competitive_outlook_non_antibody_based_cancer_vaccines.html

Piribo Product ID: BSK126

About Piribo.
Piribo (http://www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.